Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer.
about
The X-Ray Structure of Carboxypeptidase A Inhibited by a Thiirane Mechanism-Based InhibitorStructural and Functional Analysis of the Complex between Citrate and the Zinc Peptidase Carboxypeptidase AInsights into the evolution of longevity from the bowhead whale genomeCharacterization of the substrate specificity of human carboxypeptidase A4 and implications for a role in extracellular peptide processing.Association of the innate immunity and inflammation pathway with advanced prostate cancer risk.Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomasAssessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detectionGenetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.Identifying the genes regulated by IDH1 via gene-chip in glioma cell U87.Overexpression of carboxypeptidase A4 (CPA4) is associated with poor prognosis in patients with gastric cancer.Association between expression of Carboxypeptidase 4 and stem cell markers and their clinical significance in liver cancer development.Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma.Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
P2860
Q27658086-644BA410-43D0-47C1-B134-70977CE40B79Q27671316-64BFB9A2-C3BF-46F7-A6D0-B718C46B44EDQ28611130-961B7CF1-85AE-4840-9A06-1FF6344DFE53Q33897773-2DC099E7-BAD8-487D-A1B8-5EC0C92BD8FAQ34525515-7DD3B187-E783-44F8-9069-0C4829833B0AQ34634389-50100F55-61A2-4BFA-B242-A66A7FB8E6ABQ35661317-CFF42360-8EA4-47D6-993C-2F7D70EE5963Q36345332-A6EC0B59-CC8A-495D-9FF1-33D5937D6A1EQ36411730-88CBE56E-F738-4C7A-9DE0-1EF967B2B8B7Q37448252-4D257741-B03D-4E35-ABF3-0B3FCD42D375Q37604326-1EB8EF49-C13A-47EF-82AF-95C553D6D260Q37694693-C4861523-6722-41F7-9296-72C9105B14E6Q38637324-00BAC246-5888-4551-8AAF-8177F4AF4EDBQ41017874-134369F1-AD6A-44BD-8367-D538D72D280EQ50670538-EDB52646-4BFF-4FE8-96F5-EC611BC86CFC
P2860
Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Carboxypeptidase 4 gene varian ...... -to-high risk prostate cancer.
@ast
Carboxypeptidase 4 gene varian ...... -to-high risk prostate cancer.
@en
type
label
Carboxypeptidase 4 gene varian ...... -to-high risk prostate cancer.
@ast
Carboxypeptidase 4 gene varian ...... -to-high risk prostate cancer.
@en
prefLabel
Carboxypeptidase 4 gene varian ...... -to-high risk prostate cancer.
@ast
Carboxypeptidase 4 gene varian ...... -to-high risk prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Carboxypeptidase 4 gene varian ...... -to-high risk prostate cancer.
@en
P2093
Graham Casey
Iona Cheng
John S Witte
Mine S Cicek
Peter R Carroll
Phillip L Ross
P2860
P2888
P356
10.1186/1471-2407-9-69
P407
P577
2009-02-26T00:00:00Z
P5875
P6179
1031788742